Forward Citations = 19

Loading Chart...

8 inventors (with patents filed for the assignee):

Dennis W Adair (3 out of 3 patents)

Jay F Stearns (1 out of 6 patents)

Karl M Johnson (1 out of 1 patent)

4. Earl R Kern (1 out of 1 patent)

5. Rex A Jennings (1 out of 7 patents)

6. Dennie W Dyer (1 out of 1 patent)

7. Kenneth A Smiles (1 out of 1 patent)

8. Dannie H King (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 6040298 - Methods for treatment with compositions effective against (2000-03-21),

2. 5432165 - Methods for the treatment of infection caused by Hepatitis B virus (HBV) (1995-07-11),

3. 5116328 - Diagnostic kit for the detection of atypical epithelia (1992-05-26),

4. 5057616 - Podophyllotoxin purification process (1991-10-15),

Company Overview

Oclassen Pharmaceuticals, Inc. is a leading biopharmaceutical company focused on developing innovative treatments for various diseases. With a strong commitment to research and development, Oclassen Pharmaceuticals strives to improve patient outcomes and quality of life. The company's pipeline includes promising therapies in areas such as oncology, neurology, and infectious diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#38 in San Rafael, CA

#14,058 in California

#60,671 in US

San Rafael, CA, United States of America

Oclassen Pharmaceuticals, Inc.

Forward Citations = 19

8 inventors:

Dennis W Adair (3 out of 3 patents)

Jay F Stearns (1 out of 6 patents)

Karl M Johnson (1 out of 1 patent)

4. Earl R Kern (1 out of 1 patent)

5. Rex A Jennings (1 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Oclassen Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/oclassen-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]